Brooks announces Q4 of their fiscal year.
With the selling of the semi bisiness due mid year 2022,many a write off was created and the income earned from the semi secror was reported as income from discontinued opertaions.
A lot to digest, but the daily loss was big and after hours although timid in volume indicates further declines.
Not sure how to read this event, however when they announced the sale of the cryo division, price spiked and proceeded to decline until the funds were received.
Now to think like a criminal.
Your write off the kitchen sink at the year end fiscally.
In the mid part of 2022, you are about to receive 3 billion. In between, the company has 300 million cash.
Crash the stock, sell the division. Have the life sciences come out depressed in price, with 3 billion in cash plus whatever their current cash levels are, and buy back the stock to reduce the outstanding and increase your hyper growth in EPS.
Looks to me like time to save up some cash and buy the dip as the new company deals with vastly lower income without the semi secotr and watch what 3 billion in share buy backs plus acquisition idn the health care sector growing at 25 to 35 % annually.
I think it is a stall in price appreciation.
Save your cash and get readt to buy the dip.
It is time to watch the RSI.
When it hits relative lows in RSI on hourly and daily time periods, buy the dip.
Tomorrows open could be fugly.
It's a bit beyond my FA skills to be totally truthful.
Long term its a deal and it may take time.
Enjoy the discounts, if it happens.
Bob |
